Biologics products developer Bacterin International Holdings, Inc. (BONE) reported a fourth-quarter net loss of $4.3 million or $0.11 per share, narrower than last year's net loss of $6.7 million or $0.18 per share.
On average, 5 analysts polled by Thomson Reuters expected the company to report a loss of $0.03 per share for the quarter. Analysts' estimates typically exclude one-time items.
Total revenue for the quarter increased 72 percent to $9.1 million from $5.3 million last year. Analysts expected revenue of $9.5 million.
The company attributed the increase in revenue primarily to its continued market penetration, driven by unique product benefits for both the patient and medical care provider, combined with the continued expansion of its direct sales force.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.